
Hematology Billing Services
Stop Leaving Hematology Revenue on the Table Every Single Month
You didn't go into hematology to spend your evenings sorting through denied claims or chasing down biologic authorizations that someone forgot to renew. Let's just say that out loud. You went into it because blood diseases are some of the most complex and serious conditions in all of medicine, and your patients need a physician who's completely present for their care, not one who's mentally still thinking about why a rituximab infusion claim came back denied for the third time this month.
Here's what we see all the time in hematology practices. The clinical work is excellent. The documentation is solid. And yet, a meaningful chunk of revenue just doesn't make it to the practice's bank account. Sequential infusion codes that nobody captured. Drug waste from half-used vials that never made it onto a claim. Biologic authorizations that expired quietly between treatment cycles while everyone's attention was where it should have been, on the patients. None of this is negligence. It's what happens when billing that's genuinely complicated gets handed to a team that isn't built for it. MedCloudMD is built for it. We know exactly where hematology revenue disappears, and we spend every working day making sure it reaches your practice instead.
Measurable Revenue Outcomes for Hematology Practices
.png)




< 30
97%
12–18%
99%
98%
Average Days in AR
Collection Ratios
Revenue Improvement
First Pass Ratio
Clean Claims Accuracy
Full-Cycle RCM
Our Hematology Billing Services End to End
Picture a typical infusion day for one of your lymphoma patients. They're receiving a primary chemotherapy agent. A pre-medication is running at the same time. After the first infusion finishes, a supportive drug follows. That's one appointment. Three drugs. Each one codes differently based on timing and sequence. Each one needs a J-code with the right NDC number and the right unit count. Get any detail wrong and you're either underpaid or looking at a denial on a claim worth several hundred dollars. Now multiply that across a full week of infusion patients. That's what hematology billing actually looks like. It's what our team manages every single day, and we're genuinely good at it.
.png)
Eligibility Verification and Prior Authorization
Nobody wants to find out after a CAR-T infusion that the authorization expired ten days ago and nobody filed a renewal. That conversation is painful, and it's entirely preventable. We verify every patient's coverage before each encounter and confirm every active authorization for biologics, monoclonal antibodies, and factor replacement therapy is current and in place before your clinical team walks into the room.
.png)
Infusion Sequence and Drug Administration Coding
The first drug in a session codes differently than the second. The second codes differently than a drug that runs at the same time as the first. Most billing teams know one of those rules. Our AAPC certified coders know all of them and apply every code correctly across every session so your practice captures the full reimbursement for every single agent administered, not just the primary one.
.png)
J-Code Billing and NDC Documentation
A missing NDC number on a drug claim is enough for a lot of payers to reject the whole thing without even reading the rest of it. Wrong unit count means underpayment at best, a future recoupment audit at worst. We build every drug claim with the right J-code, the correct NDC, and the exact units based on what was actually administered to that specific patient in that specific session every time..
.png)
Claim Submission and Pre Submission Review
We review every hematology claim before it's submitted. Not most of them. Every single one. Infusion sequences, J-codes, NDC numbers, modifier requirements, authorization status, and eligibility are all checked at the claim level. If something doesn't look right, we correct it then and there. Your team shouldn't be discovering billing errors from a denial that shows up three weeks after the appointment.
.png)
Denial Management and Appeals
Getting a denied hematology claim back on track isn't as simple as clicking resubmit. Medical necessity disputes on biologics require detailed clinical documentation. Infusion sequence denials require showing the payer exactly why each code reflects what actually happened in the session. We build proper appeals and we follow every denied claim all the way through to payment. We don't walk away from a claim just because the first attempt came back.
.png)
Accounts Receivable and Financial Reporting
High claim values mean aging AR gets expensive fast in hematology. We work every open balance on the correct payer-specific timelines, escalate before accounts cross recovery thresholds, and deliver clear monthly reporting on your collections, denial trends, and overall revenue performance. You should always know exactly where your practice stands financially without having to dig for it yourself.
Benefits to Hire MedCloud MD
✔ AI-Driven Billing That Maximizes Every Claim
✔ Geriatrics-Specific Billing Expertise
✔ AAPC Certified Coding Team
✔ Significantly Reduced Days in AR
✔ Full Transparency, No Surprises
✔ Dedicated Account Management
✔ Seamless EHR & Practice Management Integration
Your Hematology Practice is Likely Losing Revenue Right Now

Here's the one nobody sees coming until we show them. When your team gives more than one drug in a single infusion session, the first agent gets one code and everything that follows gets its own separate code depending on whether it ran at the same time as the first drug or one after the other. Most billing teams capture the primary code and move on. They have no idea they've left the sequential and concurrent administration charges sitting there unbilled on every one of those visits. And this isn't a small amount. Across a full week of infusion patients, that's a real and significant number. Across a year, it's one of the largest revenue gaps we find in hematology practices, and almost nobody realizes it's happening until we actually run the numbers together.
2. Undercaptured J-Codes for Specialty Hematologic Drugs
Rituximab. Bortezomib. Factor VIII and factor IX replacement products. Monoclonal antibodies for multiple myeloma. Every one of these drugs has a specific J-code that needs to appear on the claim with the right units of service and the matching NDC number. When J-codes go out with incorrect unit counts or missing NDC data, payers either cut the payment or reject the entire claim. And because these are high-value drugs with high individual claim amounts, a single coding error on one biologic claim can cost your practice more on a single appointment than most billing mistakes cost in a whole month. These aren't minor administrative errors. They're expensive ones that keep repeating until someone actually fixes the underlying workflow.
3. Prior Authorization Gaps for Biologics and Targeted Therapies
CAR-T cell therapy. Checkpoint inhibitors. Monoclonal antibodies for blood cancers. All of them require authorization from virtually every payer, and those approvals have expiration dates that don't wait around for a busy practice to catch up. When an authorization expires between treatment cycles without a renewal in place, it doesn't just affect the drug claim. Payers often deny the associated administration charges on top of it. That's why MedCloudMD tracks every single active authorization across your patient panel and files renewals well ahead of the expiration date. This particular category of denials simply stops showing up in your billing queue. That's what consistent, proactive management actually looks like in practice.
4. Drug Waste That Never Makes It Onto a Claim
When a single-dose vial gets opened for a patient and only part of it is actually administered, the unused portion can be billed as drug waste under Medicare and many commercial payers. This isn't a gray area or a billing shortcut. It's a completely legitimate charge that reflects the real cost of a drug your practice purchased and opened and cannot use for anyone else. But capturing it requires documentation at the point of administration and a specific coding step that's genuinely easy to skip in a busy infusion suite where everyone's focused on the patient in front of them. Most hematology practices never bill drug waste at all. Most of them genuinely have no idea what that's been costing them annually until we sit down and show them the actual number.
5. Bone Marrow Procedures Coded as a Single Service
Bone marrow biopsy and bone marrow aspiration are two separate procedures with two separate CPT codes. When both are performed in the same session, which happens all the time in hematology, both codes need to be on the claim. When a claim goes out with only one code, or when both procedures get lumped under a general evaluation and management code because nobody stopped to identify the specific procedure codes, your practice takes a meaningful reimbursement hit on every one of those encounters. We look specifically for this in bone marrow procedure notes because it's one of the most consistently overlooked billing opportunities in hematology, and it's one of the easiest to fix once someone's actually paying attention to it.
Why Hematology Practices Choose MedCloudMD
✔ AI-Driven Billing That Maximizes Every Claim
✔ Hematology Is a Core Specialty Focus — Not a Side Service
✔ AAPC Certified Coders with Drug Billing Expertise
✔ Significantly Reduced Days in AR
✔ Full Transparency on High-Value Claim Status
✔ A Dedicated Account Manager Who Knows Your Practice
✔ Seamless EHR & Practice Management Integration
Where Hematology Practices Bleed Revenue Every Single Month
%20(1)%20(1)%20(1).jpg)
Infusion billing follows a strict hierarchy: the primary infusion code goes first, then concurrent infusions, then sequential infusions. When that sequence is applied incorrectly or when the wrong code is used as the primary claims get denied or significantly underpaid. Most billing teams don't know where to start when this happens, so the revenue disappears.
Missed or Miscalculated J-Code Billing
J-codes must be billed in units that exactly match the drug administered, with the correct NDC number attached and dosage rounding applied per payer policy. A unit calculation error on a drug like rituximab (J9312) or bortezomib (J9041) can mean thousands of dollars lost per claim and many payers won't catch the underbilling for you.
Modifier Errors on Complex Procedures
Bone marrow biopsies, therapeutic phlebotomies, and transfusion services all require specific modifier combinations to reflect the clinical context accurately bilateral procedures, multiple units, or the distinction between unilateral and staged services. A wrong modifier or a missing one routinely triggers automated denials that take weeks to resolve and months to appeal successfully.
Prior Authorization Failures for Biologics
High-cost hematology biologics erythropoiesis-stimulating agents, IVIG, colony-stimulating factors require prior authorization that must be renewed on schedule and documented with current lab values supporting medical necessity. One lapse in the PA workflow triggers a post-service denial that is extraordinarily difficult to reverse, especially for Medicare Advantage plans.
Medical Necessity Denials for Labs
CBC panels, coagulation studies, ESR, iron studies, and bone marrow lab panels are all billable services but only when the clinical documentation clearly links each test to a specific, active diagnosis on the claim. When that linkage is absent or vague, labs get bundled or denied as medically unnecessary. This is one of the most common and most avoidable revenue losses in hematology.
Drug Wastage Not Billed
When a single-use vial isn't fully used in a treatment, the remaining drug if medically reasonable to discard can be billed using the JW modifier for Medicare and many commercial payers. Most hematology practices never bill wastage at all. Over a year of infusion sessions, this adds up to a surprisingly significant amount of recoverable revenue that simply never gets captured.
AI-Powered Billing Built for Hematology's Complexity
MedCloudMD's AI layer works across your entire revenue cycle catching J-code errors before submission, flagging prior auth gaps in real time, and prioritizing your highest-value claims for recovery.
Prior Authorization Automation

AI tracks every active prior authorization across your patient population monitoring expiration dates, flagging upcoming renewals, and alerting your team when supporting documentation needs to be updated. No biologic treatment should ever be denied because a PA lapsed quietly while your staff was focused on patient care.
J-Code Drug Unit Validation

Our AI engine automatically validates drug dosage unit calculations against the administered quantity documented in the clinical record catching rounding errors, unit mismatches, and missing NDC numbers before they become underpayments. For high-volume infusion centers, this single capability alone recovers significant revenue every month.
Predictive Denial Prevention

AI cross-references your hematology claims against current payer-specific infusion billing policies, Medicare LCD guidelines, and J-code coverage rules before submission. High-risk claims get flagged and corrected before they ever reach the payer stopping denials at the source rather than fighting them after the fact.
Revenue Analytics & Drug Revenue Tracking

AI generates drug-level revenue reports so you can see exactly which hematology drugs are driving the most revenue, where reimbursement rates have shifted with CMS ASP updates, and where drug revenue is being eroded by underbilling or denial patterns. This financial intelligence helps you manage your infusion program as a revenue center, not just a clinical service.
Real-Time Eligibility & Coverage Verification

Automated eligibility checks run before every patient appointment confirming Medicare Part B drug coverage, Medicare Advantage plan infusion benefits, and commercial payer formulary inclusion for scheduled infusion drugs. Coverage gaps are surfaced before the treatment date, not after the claim is submitted.
Smart AR Follow-Up Prioritization

Given that individual hematology claims can be worth thousands of dollars, how you prioritize AR follow-up has a direct impact on monthly collections. MedCloudMDs AI ranks your aging claims by dollar value, payer response patterns, and denial category so your team's follow-up time is always applied where the return is highest.
This Is Not Standard Medical Billing. Not Even Close.
Hematology billing sits at the intersection of high-cost pharmaceuticals, multi-step infusion protocols, oncology coding overlap, and some of the most scrutinized claim types in all of Medicare. A single patient encounter can involve drug administration, lab draws, and physician evaluation each requiring its own codes, modifiers, and documentation standards, all on one claim.
The financial stakes here are unlike most specialties. A chemotherapy infusion session billed incorrectly doesn't cost you $30 it can cost you $2,000 to $8,000 on a single date of service. J-code drug billing errors, infusion sequencing mistakes, and incorrect modifier application are invisible in day-to-day practice operations but devastating over a billing year.
Add in the complexity of prior authorization for high-cost biologic drugs, Medicare Part B drug coverage rules, and payer-specific infusion billing policies that shift regularly and it's clear why hematology billing cannot be handed off to a generalist billing team and expected to perform well.
High-Cost Infusion Therapy
We work in hematology and infusion billing every single day. Infusion sequence rules, J-code and NDC requirements for every major drug class your practice uses, documentation standards for high-cost biologic claims
Every claim we submit has been checked against the rules your specific payers are currently applying. That's why our hematology clients see meaningfully lower denial rates than the specialty average.
J-Code Drug Reimbursement
From patient eligibility all the way through J-code submission, authorization management, denial appeals, and final AR recovery, MedCloudMD owns your entire hematology revenue cycle. Every step connects to the next.
Oncology-Hematology Overlap
High-cost hematology drugs and procedures routinely require prior authorization — and one expired or incomplete approval can cause an entire treatment series to go uncompensated. The PA workflow here demands proactive management, not reactive catch-up.
Intensive Prior Authorization
Your Hematology Practice Is Processing High-Value Claims Every Day. Make Sure Every Dollar Gets Paid.
Infusion sequencing errors, J-code miscalculations, and prior authorization gaps are costing your practice real money on claims it has already delivered. Our free hematology billing audit identifies every revenue leak with a recovery plan attached in under 48 hours.

Frequently asked questions
- 01
- 02
- 03
- 04
- 05
- 06
- 07



.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)